{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-24-000017","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.001049+00:00","generated_at":"2026-06-01T23:03:45.696474+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intensity Therapeutics appoints Thomas Dubin to Board, restores Audit Committee compliance","bullets":["Thomas I. H. Dubin appointed as Class I director, expanding Board from 4 to 5 members.","Dubin will serve on Audit Committee, restoring Nasdaq compliance after Daniel Donovan's resignation.","Granted options to purchase 50,000 shares at $4.42 per share, vesting in four equal installments.","Dubin brings deep experience from Alexion Pharmaceuticals (former chief legal officer) and other biotech roles.","Four of five Board members are now independent per Nasdaq standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-24-000017","json":"https://secwatch.observer/filing/0001567264-24-000017.json","markdown":"https://secwatch.observer/filing/0001567264-24-000017.md","text":"https://secwatch.observer/filing/0001567264-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/0001567264-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/intensity-20240514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:03:45.696474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"efad87d5f5","claim":"Thomas I. H. Dubin was appointed as Class I director at INTENSITY THERAPEUTICS, INC..","evidence_excerpt":"appointed Thomas I. H. Dubin to the Board as a Class I director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/0001567264-24-000017-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}